DEPO Depomed, Inc. (delisted)

Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in fireside chats at the following healthcare conferences during the month of March.

30th Annual ROTH Capital Partners Conference

Date: Tuesday, March 13, 2018 Time: 12:30 p.m. PDT/ 3:30 p.m. EDT Location: Dana Point, California

Oppenheimer 27th Annual Healthcare Conference

Date: Tuesday, March 20, 2018 Time: 1:35 p.m. EDT Location: New York, New York

The fireside chats will be webcast live and may be accessed via the Investor Relations’ page of the Depomed website at www.depomed.com.  A recording of these events will be archived for 30 days on the company's website.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of patients, families, physicians, providers and payors through the commercialization of products in the areas of pain and neurology, and in the development of drugs in areas of unmet medical need. Depomed currently markets three medicines focused on neuropathic pain and migraine through its neurology and pain franchises and its emerging specialty/orphan franchise is focused on orphan drug indications and areas of unmet medical need. To learn more about Depomed, visit www.depomed.com. 

Investor and Media Contacts:

Christopher Keenan VP, Investor Relations and Corporate Communications 510-744-8000 ckeenan@depomed.com

Dan Peisert VP, Business Development dpeisert@depomed.com